Biomaterials and medical device company Aortech International on Tuesday signed a development agreement with Vascular Flow Technologies (VFT) for the development of a synthetic heart valve. The project undertaken by the duo will see detailed computational modelling and analysis of AIM traded firm AorTech's heart valve before design optimisation, manufacturing and testing commences with the objective of preparing data to justify 'in man' testing of the technology. VFT is a medical device ...Den vollständigen Artikel lesen ...
© 2018 LiveCharts.co.uk